Trends in Sudden Death Among Schizophrenia Inpatients

<i>Background and Objectives:</i> Schizophrenia is associated with a 15-20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. <i>Materials and Methods</i>: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. <i>Results</i>: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989-2013 cohort, which included 57 sudden deaths, the incidence during 2014-2024 declined substantially (0.27% vs. 0.79%). <i>Conclusions</i>: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989-2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2025-11-22
DOI
https://doi.org/10.3390/medicina61122081
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in Sudden Death Among Schizophrenia Inpatients

Daniel Țâbian, Paula Simina Petric, Andreea Teodorescu, Petru Ifteni et al.
Medicina
Schizophrenia research and treatment
article

Trends in Sudden Death Among Schizophrenia Inpatients

Daniel Țâbian, Paula Simina Petric, Andreea Teodorescu, Petru Ifteni, Abbie M. Popa
article en

Abstract

<i>Background and Objectives:</i> Schizophrenia is associated with a 15-20-year reduction in life expectancy, with cardiovascular disease as the leading cause. Sudden unexpected death is common in this population, often linked to structural heart disease, antipsychotic use, and overlapping cardiometabolic, autonomic, and drug-related factors. This study aimed to determine the incidence and causes of sudden unexpected death among schizophrenia inpatients between 2014 and 2024 and compare these findings with historical data from the same institution. <i>Materials and Methods</i>: We conducted a retrospective cohort study of schizophrenia inpatients admitted from January 2014 to December 2024. Hospital records were reviewed to identify sudden and unexpected deaths, verified by the Forensic Medicine Service Brașov. Sudden death was defined as death in an asymptomatic patient or within one hour of new symptom onset, excluding suicide, homicide, or accidental overdose. In accordance with Romanian legislation, an autopsy was performed in every case. <i>Results</i>: Over the 10-year period, six schizophrenia inpatients (mean age 53.2 ± 17.8 years) died suddenly. All had long-standing schizophrenia (mean illness duration 28.7 ± 17.7 years) and were receiving second-generation antipsychotics. Cardiovascular comorbidity was present in three cases. All patients received antipsychotic treatment within 24 h before death. No deaths occurred within the first 24 h of admission; one occurred within 48 h. Compared with the 1989-2013 cohort, which included 57 sudden deaths, the incidence during 2014-2024 declined substantially (0.27% vs. 0.79%). <i>Conclusions</i>: The incidence of sudden unexpected death among schizophrenia inpatients declined significantly over the past decade compared with the 1989-2013 cohort, reflecting improved multidisciplinary care, prompt transfer to general hospitals, and wider use of second-generation antipsychotics. Autopsy findings emphasize the continuing importance of cardiovascular disease and airway obstruction as preventable causes of sudden death in this population.

MedicinaVol. 61(12)
Transylvania University of Brașov (RO), Fundaţia pentru Formare Profesională şi Învăţământ Preuniversitar - Viitor (RO)
Openalex Percentile: Top 58%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.